AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimrator-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bkyula Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimrator-M1 Tablet SR

DiaBeta-Duo SR tablets are antidiabetic medications combining two agents for adult type 2 diabetes management. This medication helps regulate blood glucose. DiaBeta-Duo SR should be taken with meals, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this medication as prescribed, even if feeling well or with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision loss, neuropathy, and limb loss. This medicine is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, tremors—and how to manage them. Regular meals and carrying a quick-acting glucose source (sugary foods or juice) are essential. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your doctor of any heart history before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your physician, is necessary.

Uses of Glimrator-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimrator-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrator-M1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Glimrator-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimrator-M1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimrator-M1 Tablet SR should be administered with a meal.

How Glimrator-M1 Tablet SR works:

Glimrator-M1 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, works through a threefold mechanism: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's responsiveness to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimrator-M1 Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimrator-M1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimrator-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity associated with the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimrator-M1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimrator-M1 SR tablets cautiously, potentially requiring dosage modification. Consult your physician. For individuals with mild to moderate liver disease, Glimrator-M1 SR tablets are typically initiated at a low dose; however, their use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimrator-M1 Tablet SR :

Should you forget a Glimrator-M1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimrator-M1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimrator-M1 Tablet SR

Store this medication in its original, tightly sealed container or packaging, following the storage directions provided on the label. Discard any leftover medication appropriately. Prevent access by children, pets, and other individuals.
Glimrator-M1 Tablet SR use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more prevalent in individuals with kidney impairment, the elderly, or those consuming significant amounts of alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glimrator-M1 Tablet SR and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimrator-M1 SR tablets, manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when coupled with a suitable diet and consistent physical activity. Glimepiride's mechanism involves stimulating pancreatic insulin secretion, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose output and increasing insulin responsiveness. This dual therapy is unsuitable for type 1 diabetes.
Glimrator-M1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimrator-M1 Tablet SR use may lead to Vitamin B12 deficiency due to impaired gastric absorption of the vitamin. This deficiency, if left unaddressed, can result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, according to some studies, include annual supplemental Vitamin B12 intake.
Glimrator-M1 SR tablets can induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar may include nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimrator-M1 Tablet SR and alcohol is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimrator-M1 Tablet SR
40
MRP 49
18% off